GB449468A - Process for the production of a product containing magnesium for therapeutic purposes and industrial purposes - Google Patents
Process for the production of a product containing magnesium for therapeutic purposes and industrial purposesInfo
- Publication number
- GB449468A GB449468A GB33292/34A GB3329234A GB449468A GB 449468 A GB449468 A GB 449468A GB 33292/34 A GB33292/34 A GB 33292/34A GB 3329234 A GB3329234 A GB 3329234A GB 449468 A GB449468 A GB 449468A
- Authority
- GB
- United Kingdom
- Prior art keywords
- plants
- complex
- plant
- extracted
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cultivation Of Plants (AREA)
Abstract
Organic halogen compounds are incorporated into plants containing chlorophyll, and a complex containing a colloidal organic magnesium halogen compound extracted therefrom. Parts of plants such as stems, leaves, and needles may be treated and the whole or part of the plant used for the extraction. Plants with strongly developed parenchyme such as cacti, aloes, and agavae are preferred especially those exhibiting coloured markings such as the aucuba thunb. Organic bromine compounds, especially the lower aliphatic compounds such as ethylene bromide, brominated alcohols, aldehydes ketones, and carboxylic acids may be used, in particular ethylene bromhydrin and tribromethyl alcohol. Aqueous solutions may be employed with the addition, if necessary, of solvents, in particular glucuronic acid. The halogen compounds are incorporated in the plant by addition to the culture medium in solid form, alone or mixed with fertilizers, by watering, dusting, or spraying, by respiration in an atmosphere containing a gaseous compound or by injection as with an injection syringe. The complex formed can be extracted with distilled water or solutions of suitable osmotic pressure which cause swelling or shrinking of the plant cells, the temperature being kept below 50 DEG C. Phenols or other sterilizing agents may be added to the extraction liquid, and the plants previously washed and sterilized. Alternatively, the plants may be tapped or the complex withdrawn by means of an injection syringe. In some cases anomalies of growth such as cysts form on the plants, these being enriched in the complex. An aucuba thunb, having a rising sap stream is watered in the absence of sunlight with an aqueous solution containing 3 c.c. ethylene bromhydrin per litre, 300 c.c. being used every other day. After 3--4 weeks a brown colouration of the plant indicates formation of the complex. The leaves are cut off, sterilized with carbolic acid solution, cut into strips, drained, and 30 g. extracted with 1 litre of 0,5 per cent sodium chloride solution containing 0,5 per cent phenol, usually for 36 hours. By using larger amounts of leaf and of sodium chloride, the colloidal complex is precipitated. The product can convert carbonic acid into formaldehyde and polymerize aldehydes to higher complexes.ALSO:Organic halogen compounds are incorporated into plants containing chlorophyll, and a complex containing a colloidal organic magnesium halogen compound extracted therefrom. Parts of plants such as stems, leaves, and needles may be treated and the whole or part of the plant used for the extraction. Plants with strongly developed parenchyme such as cacti, aloes, and agav are preferred especially those exhibiting coloured markings such as the aucuba thunb. Organic bromine compounds, especially the lower aliphatic compounds such as ethylene bromide, brominated alcohols, aldehydes, ketones, and carboxylic acids may be used, in particular ethylene bromhydrin and tribromethyl alcohol. Aqueous solutions may be employed with the addition, if necessary, of solvents, in particular glucuronic acid. The halogen compounds are incorporated in the plant by addition to the culture medium in solid form, alone or mixed with fertilizers, by watering, dusting, or spraying, by respiration in an atmosphere containing a gaseous compound or by injection as with an injection syringe. The complex formed can be extracted with distilled water or solutions of suitable osmotic pressure which cause swelling or shrinking of the plant cells, the temperature being kept below 50 DEG C. Alternatively the plants may be tapped or the complex withdrawn by means of an injection syringe. In some cases anomalies of growth such as cysts form on the plants, these being enriched in the complex. An aucuba thunb, having a rising sap stream is watered in the absence of sunlight with an aqueous solution containing 3 c.c. ethylene bromhydrin per litre, 300 c.c. being used every other day. After 3--4 weeks a brown colouration of the plant indicates formation of the complex. The leaves are cut off, sterilized with carbolic acid solution, cut into strips, drained, and 30 g. extracted with 1 litre of 0,5 per cent sodium chloride solution containing 0,5 per cent phenol, usually for 36 hours. By using larger amounts of leaf and of sodium chloride, the colloidal complex is precipitated. The product can convert carbonic acid into formaldehyde and polymerize aldehydes to higher complexes.ALSO:Organic halogen compounds are incorporated into plants containing chlorophyll, and a complex containing a colloidal organic magnesium halogen compound extracted therefrom. Parts of plants such as stems, leaves, and needles may be treated and the whole or part of the plant used for the extraction. Plants with strongly developed parenchyme such as cacti, aloes, and agavae are preferred, especially those exhibiting coloured markings such as the aucuba thunb. Organic bromine compounds, especially the lower aliphatic compounds such as ethylene bromide, brominated alcohols, aldehydes, ketones, and carboxylic acids may be used, in particular ethylene bromhydrin and tribrom-ethyl alcohol. Aqueous solutions may be employed with the addition, if necessary, of solvents, in particular glucuronic acid. The halogen compounds are incorporated in the plant by addition to the culture medium in solid form, alone or mixed with fertilizers, by watering, dusting, or spraying, by respiration in an atmosphere containing a gaseous compound, or by injection as with an injection syringe. The complex formed can be extracted with distilled water or solutions of suitable osmotic pressure which cause swelling or shrinking of the plant cells, the temperature being kept below 50 DEG C. Phenols or other sterilizing agents may be added to the extraction liquid, and the plants previously washed and sterilized. Alternatively, the plants may be tapped or the complex withdrawn by means of an injection syringe. In some cases anomalies of growth such as cysts form on the plants, these being enriched in the complex. An aucuba thunb. having a rising sap stream is watered in the absence of sunlight with an aqueous solution containing 3 c.c. ethylene bromhydrin per litre, 300 c.c. being used every other day. After 3-4 weeks a brown colouration of the plant indicates formation of the complex. The leaves are cut off, sterilized with carbolic acid solution, cut into strips, drained, and 30 g. extracted with 1 litre of 0,5 per cent sodium chloride solution containing 0,5 per cent phenol, usually for 36 hrs. After filtering and standing for 4 weeks, the solution is ready for use by injection in the treatment of diseases connected with metabolism such as carcinoma. By using larger amounts of leaf and of sodium chloride, the colloidal complex is precipitated and is used for suppositories and ointments. The product can convert carbonic acid into formaldehyde and polymerize aldehydes to higher complexes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT406653X | 1934-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB449468A true GB449468A (en) | 1936-06-19 |
Family
ID=71607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB33292/34A Expired GB449468A (en) | 1934-09-29 | 1934-11-19 | Process for the production of a product containing magnesium for therapeutic purposes and industrial purposes |
Country Status (2)
Country | Link |
---|---|
BE (1) | BE406653A (en) |
GB (1) | GB449468A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2612000A (en) * | 1949-08-24 | 1952-09-30 | Arthur B Anderson | Producing extractive materials from living trees |
US3184887A (en) * | 1960-03-14 | 1965-05-25 | Madaus & Co Kommanditgesellsch | Process of producing glycosides from living plants |
GB2213373A (en) * | 1987-07-27 | 1989-08-16 | Poon Theodore Man | Po-man's photosynthesis in men's blood to cure cancer (PhMDcc) |
GB2226494A (en) * | 1988-07-20 | 1990-07-04 | Poon Theodore Man | Po-man's photosynthesis in mens blood to cure cancer and Poon's production function synthesis |
-
1934
- 1934-11-19 GB GB33292/34A patent/GB449468A/en not_active Expired
- 1934-12-05 BE BE406653A patent/BE406653A/fr unknown
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2612000A (en) * | 1949-08-24 | 1952-09-30 | Arthur B Anderson | Producing extractive materials from living trees |
US3184887A (en) * | 1960-03-14 | 1965-05-25 | Madaus & Co Kommanditgesellsch | Process of producing glycosides from living plants |
GB2213373A (en) * | 1987-07-27 | 1989-08-16 | Poon Theodore Man | Po-man's photosynthesis in men's blood to cure cancer (PhMDcc) |
GB2213373B (en) * | 1987-07-27 | 1991-05-08 | Poon Theodore Man | Po-man's photosynthesis in men's blood to cure cancer (phmdcc) |
GB2226494A (en) * | 1988-07-20 | 1990-07-04 | Poon Theodore Man | Po-man's photosynthesis in mens blood to cure cancer and Poon's production function synthesis |
GB2226494B (en) * | 1988-07-20 | 1991-10-09 | Poon Theodore Man | Photosynthesis in men's blood to cure cancer-part 2 phmd(cancer) |
Also Published As
Publication number | Publication date |
---|---|
BE406653A (en) | 1935-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Francis Jr | Transmission of influenza by a filterable virus | |
Cavallito et al. | Allicin, the antibacterial principle of Allium sativum. I. Isolation, physical properties and antibacterial action | |
Long | The effect of salt additions to the substrate on intake of water and nutrients by roots of approach-grafted tomato plants | |
Swart et al. | Fradicin, an Antifungal Agent produced by Streptomyces fradiae. | |
Trelease et al. | Susceptibility of wheat to mildew as influenced by carbohydrate supply | |
GB449468A (en) | Process for the production of a product containing magnesium for therapeutic purposes and industrial purposes | |
Kavanagh et al. | Antibiotic Substances from Basidiomycetes: V. Poria Corticola, Poria Tenuis and an Unidentified Basidiomycete | |
GB934554A (en) | Methods of obtaining substantially stable concentrated extracts of red vine (vitis vinifera) and the extracts resulting therefrom | |
US2638431A (en) | 2-norcamphanemethanol and 2-norcamphanemethoxyethanol applied to plants to inhibit fungous growths | |
Longman | Initiation of flowering on first year cuttings of Metasequoia glyptostroboides Hu and Cheng | |
GB444276A (en) | An improved process for the manufacture of medicinal preparations containing chlorophyll or chlorophylline | |
US4132782A (en) | Method for suppressing herpes simplex virus | |
US2178270A (en) | Horticultural germicide | |
Shoppee et al. | 93. Constituents of the bark of Balanops australiana F. Muell | |
CAVALLITO et al. | Isolation of Visnagan, the Amorphous Coronary-Dilator Principle of Ammi visnaga | |
Kramer et al. | Significance of the pH of blueberry leaves | |
Nelson et al. | The presence in self-blanching celery of unsaturated compounds with physiological action similar to ethylene | |
Christie | Two distinct strains of the nematode Aphelenchoides fragariae occurring on strawberry plants in the United States | |
Sciuchetti et al. | The effects of atropine and 2, 4‐dichlorophenoxyacetic acid on leaf alkaloid accumulation in certain members of the Solanaceae | |
Gardner et al. | Parthenocarpic fruits induced by spraying with growth-promoting chemicals | |
Reinhard et al. | Some pharmacologic characteristics of isonicotinyl hydrazide (Pyricidin®), a new antituberculosis drug | |
Smith et al. | THE ESSENTIAL OIL OF AGATHOSMA APICULATA MEYER | |
Drake | 572 Vol. 45, No. 7--PLANT DISEASE REPORTER--July 15, 1961 RHIZOCTONIA CROWN ROT OF BIRDSFOOT TREFOIL (LOTUS CORNICULATUS) ¹ | |
GB459531A (en) | Improvements in or relating to the manufacture of cellulose | |
SU62757A1 (en) | A method for extracting pyrethrins from Dalmatian chamomile, etc. of plants |